BridgeMD
New treatment option for Chronic Lymphocytic Leukemia
Official title A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ClinicalTrials.gov ID: NCT07218341
What this study is testing
What is Pirtobrutinib?
Pirtobrutinib is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for chronic lymphocytic leukemia.
Also referred to as LY3527727.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study is open to those who completed J2N-MC-JZNN/LOXO-BTK-20020 (NCT 04666038) for continued access to the study intervention or continued follow-up visits.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Are actively participating in study J2N-MC-JZNN/LOXO-BTK-20020
You likely can't join if
- This is not applicable to this study
The study team makes the final eligibility decision.
Where it's taking place
- Mobile, Alabama, United States
- Tucson, Arizona, United States
- Jacksonville, Florida, United States
- Coon Rapids, Minnesota, United States
- Ithaca, New York, United States
- New York, New York, United States
- Cincinnati, Ohio, United States
- Fort Worth, Texas, United States
- Kyle, Texas, United States
- Melbourne, Australia
- Salzburg, Austria
- Roeselare, Belgium
- Toronto, Canada
- Beijing, China
- Changsha, China
- Guangdong, China
- Guangzhou, China
- Lanzhou, China
- Nanchang, China
- Shanghai, China
+ 28 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mobile, Alabama, United States; Tucson, Arizona, United States; Jacksonville, Florida, United States; Coon Rapids, Minnesota, United States; Ithaca, New York, United States; New York, New York, United States and 42 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.